FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0.444. It has been cited 11 times, with 7 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0.0708
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 7 citers.
NIH
Grant: R01CA237154
NIH
Grant: R01CA275128
NIH
Grant: 5P30CA45508
NCI NIH HHS
Grant: P30 CA045508
NIH HHS
Grant: 1R01CA275128
National Institutes of Health
Grant: 3P30CA045508-08S1
CSHL CANCER CENTER SUPPORT GRANT
National Institutes of Health
Grant: 5R01CA237154-04
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer
National Institutes of Health
Grant: 4R01CA275128-04
Metastasis of PTEN Mutant Prostate Cancer
FWCI
1.81
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals